CHPA interim president?
This article was originally published in The Rose Sheet
Executive Summary
Consumer Healthcare Products Association reportedly offered board member and healthcare consultant Robert Donovan position of interim president. Donovan, who heads consultancy firm Robert Donovan LLC, formerly led consumer pharmaceuticals business at Sandoz Pharmaceuticals and also worked in consumer products division at Pfizer. He was first elected to CHPA board in 1990. If Donovan accepts, he will succeed Michael Maves, MD, who will leave the association Jan. 15 to head American Medical Association (1"The Rose Sheet" Nov. 26, In Brief)...
You may also be interested in...
CHPA initiates search for president
Consumer Healthcare Products Association is commencing search for a new president after Michael Maves, MD, was appointed to head American Medical Association Nov. 19. Maves will take over as AMA exec VP/CEO effective Jan. 15, departing CHPA after two years. Maves took the helm at CHPA not long after OTC trade group, formerly known as Nonprescription Drug Manufacturers Association, expanded its membership to include dietary supplement companies...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.